Lasa Supergenics Share Price

Lasa Supergenerics Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (API) bulk drugs products. The Company is engaged in the business of manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and others. It specializes in catalyst chemistry and manufactures anthelmintic/ veterinary API products with production capabilities and product categories in India. The Company's products include API products, other API products, animal feed ingredients and reagents for therapeutic use. Its API products include Fenbendazole, Toldimphos sodium, Cyromazine, Albendazole, Riclabendazole, Rafoxanide, Ornidazole, 2,6-Diiodo-4-Nitrophenol, Ricobendazole, Oxfendazole, Closantel Base, Closantel sodium, Nitroxynil, Halquinol, and Oxyclozanide. The Company's manufacturing facility is located in Chiplun, Maharashtra.As of 15 Jun 2026, Lasa Supergenics share price is ₹7.19. The stock opened at ₹7.54, compared to its previous close of ₹7.18. During today's trading session, Lasa Supergenics share price moved in the range of ₹6.76 to ₹7.54, with an average price of ₹7.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹6.76 and a high of ₹7.54. On the performance front, Lasa Supergenics share price has declined by 25.26% over the last six months and is down 45.90% on a year-on-year basis.

The market capitalization of Lasa Supergenics is ₹36 Crs, with a P/E ratio of -1.1 and a dividend yield of 0.00%.